TFF PHARMACEUTICALS, INC. Financing Cash Flow
TFF PHARMACEUTICALS, INC. reported Financing Cash Flow of $5.52 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $199.06K, a 96.09% decline year-over-year.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $4.42M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $901.14K.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $567.00, a 99.99% decline year-over-year.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $5.01M, a 57.34% decline from fiscal 2022.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $11.75M, a 59.32% decline from fiscal 2021.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $28.88M, a 15.56% increase from fiscal 2020.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2020 was $24.99M, a 13.96% decline from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 1 month as first filed | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $199.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $4.62M derived: sum of 2 quarters · filed 2024-11-20 | $5.52M 10-Q · filed 2024-11-20 | $5.53M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2024-06-30 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $5.33M 10-Q · filed 2024-08-14 | $5.33M derived: sum of 3 quarters · filed 2024-08-14 | $10.42M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2024-03-31 | $901.14K 10-Q · filed 2024-05-14 | $901.71K derived: sum of 2 quarters · filed 2024-05-14 | $5.99M derived: sum of 3 quarters · filed 2024-11-20 | $5.93M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2023-12-31 | $567.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.09M derived: sum of 2 quarters · filed 2024-11-20 | $5.03M derived: sum of 3 quarters · filed 2024-11-20 | $5.01M 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | $5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | $5.03M derived: sum of 2 quarters · filed 2024-11-20 | $5.01M 10-Q · filed 2024-11-20 | $16.35M derived: sum of 4 quarters · filed 2024-11-20 | ||||
| 2023-06-30 | -$59.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$77.15K 10-Q · filed 2024-08-14 | $11.26M derived: sum of 3 quarters · filed 2024-08-14 | $11.69M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$17.92K 10-Q · filed 2024-05-14 | $11.32M derived: sum of 2 quarters · filed 2024-05-14 | $11.75M derived: sum of 3 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | $11.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $11.77M derived: sum of 2 quarters · filed 2024-03-28 | $11.75M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $430.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $414.74K 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$15.99K 10-Q · filed 2023-08-14 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $25.95K derived: sum of 3 quarters · filed 2023-03-31 | $28.88M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $25.95K derived: sum of 2 quarters · filed 2022-11-14 | $28.88M 10-Q · filed 2022-11-14 | $29.60M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $25.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $28.88M 10-Q · filed 2022-08-11 | $29.60M derived: sum of 3 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $28.86M 10-Q · filed 2022-05-11 | $29.57M derived: sum of 2 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $714.38K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $24.99M 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | $24.28M 10-Q · filed 2021-11-15 | |||||||
| 2019-12-31 | $21.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $21.84M derived: sum of 2 quarters · filed 2021-03-10 | $29.05M 10-K · filed 2021-03-10 | |||||
| 2019-09-30 | -$10.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.20M 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | $7.21M 10-Q · filed 2020-08-13 | |||||||
| 2018-12-31 | $12.39M 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | $12.48M 10-Q · filed 2019-12-09 | |||||||
| 2018-01-23 | $1.83K 10-K · filed 2020-03-27 | -$1.83K 10-Q · filed 2019-12-09 |